Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the supply of Agomelatine.

The Department fully understands that maintaining access to agomelatine for the management of major depression is vitally important to many people in this country.

We are aware that Teva a supplier of generic agomelatine 25mg tablets discontinued supplies in July 2019. However, we can confirm that supplies of agomelatine 25mg tablets are currently available from several other suppliers in volumes that are sufficient to meet normal United Kingdom demand. All patients who require agomelatine should be able to obtain a supply from their pharmacy.

We continue to work closely with industry and partners in the health system to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.